{
 "id": "252942",
 "text": "Azoximer bromide is a macromolecular compound with high-molecular weight and not proved immunomodulating activity. It is using in CIS countries for treatment and prophylaxis of diseases connected with damage of immune system. It is a N-oxidized polyethylene–piperazine derivative. Azoximer bromide is sold under the trade name Polyoxidonium. Polyoxidonium is registered in US Patent-5503830 from 1996,http://www.google.com/patents/about?id=s9cfAAAAEBAJ&dq;=US+5503830http://www.wikipatents.com/US- Patent-5503830/compounds-having-immunostimulating-activity-and-methods-of-use- thereof in the Russian Federation from 1996, under registration number 96/302/9, FS 42-3906-00.State Scientific Centre of Russian federation, Immunological Institute of Russian Federation Health Resort, CLINICAL ASPECTS OF USE OF IMMUNOMODULATOR POLYOXIDONIUM, Methodical handbook for doctors issued by State Scientific Centre of Russian Federation – Immunological Institute of Russian Federation Health Resort Moscow – 2003 == References == Category:Immunology Category:Drugs Category:Polymers",
 "title": "Azoximer bromide"
}